Controlled trial to evaluate protection of high-risk infants against respiratory syncytial virus disease by using standard intravenous immune globulin.

We performed a randomized, controlled trial of intravenous immune globulin (respiratory syncytial virus [RSV] neutralizing [Nt] antibody titer of 1:950 in 5% solution) to evaluate protection against RSV-induced disease over two respiratory virus seasons. Forty-nine children (mean age at enrollment,...

Celý popis

Uloženo v:
Podrobná bibliografie
Hlavní autoři: Meissner, H C, Fulton, D R, Groothuis, J R, Geggel, R L, Marx, G R, Hemming, V G, Hougen, T, Snydman, D R
Médium: Artigo
Jazyk:Inglês
Vydáno: 1993
Témata:
Research Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC188036/
https://ncbi.nlm.nih.gov/pubmed/8215279
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky